CCFA Launches Live Webinar Series for Health Care Professionals in March & April

Share Article

Optimizing Care for Patients with IBD: Highlights from the “Advances in IBD” Conference

WHO:
This live and interactive webinar series will be of immediate clinical value for gastroenterologists, pediatric gastroenterologists, internists, gastroenterology nurses and other nurses, inflammatory bowel disease (IBD) surgeons, and other healthcare professionals.

WHAT:
Over 1.4 million Americans live with Crohn’s disease and ulcerative colitis, chronic and often debilitating digestive diseases, collectively known as inflammatory bowel disease (IBD). To help health care professionals better treat their patients, the Crohn’s & Colitis Foundation of America, with financial support from Centocor Ortho Biotech Inc., is offering a new series of three engaging and interactive one hour accredited live webinars at no cost to attendees. The webinars will contain highlights from the most widely attended presentations and seminars delivered by IBD thought leaders from the 2010 Advances in IBD Crohn’s & Colitis Foundation’s Clinical & Research Conference and will include question and answer sessions. The series will cover challenges in the clinical management of IBD patients, current controversies in IBD treatment, and the latest in genetics, risks, and therapy management in IBD. The UAMS College of Medicine designates each live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity has been submitted to the Society of Gastroenterology Nurses and Associates, Inc. for approval. The Society of Gastroenterology Nurses and Associates, Inc. is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation.

WHERE:
Register easily online and at no cost at http://www.ccfaibdwebinars.org

Sessions are designed to fit into health care professionals’ busy practice schedule and feature relevant and compelling topics. This one-hour accredited activity will be broadcast live via the internet.

WHEN:
Tuesday, March 15, 2011, 6 pm EST, Challenges in the Clinical Management of IBD Patients
Tuesday, April 12, 2011, 6 pm EST, Current Controversies in IBD Treatment
Tuesday, April 26, 2011, 6 pm EST, The Latest in Genetics, Risks, and Therapy Management in IBD

WHY:
The Crohn’s & Colitis Foundation is proud to present this new series as part of its commitment to furthering professional IBD education year-round. The Foundation is committed to providing the medical community with the necessary educational resources to provide optimal care for patients.

About Crohn's Disease & Ulcerative Colitis
Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere from the mouth to the anus, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Arkansas for Medical Sciences (UAMS) College of Medicine and the Crohn's and Colitis Foundation of America. The UAMS College of Medicine is accredited by the ACCME to provide continuing education for physicians.

About the Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 81 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance (give.org) and the American Institute of Philanthropy (charitywatch.org). For more information, contact the Foundation at 800-932-2423 or visit http://www.ccfa.org. Join CCFA on Facebook at http://apps.facebook.com/supportccfa/and follow CCFA on Twitter at http://www.twitter.com/ccfa.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ariella Levine
Visit website